Monoclonal antibodies to pertussis toxin: utilization as probes of toxin function.

PubWeight™: 1.43‹?› | Rank: Top 5%

🔗 View Article (PMID 2466764)

Published in Hybridoma on February 01, 1989

Authors

J G Kenimer1, K J Kim, P G Probst, C R Manclark, D G Burstyn, J L Cowell

Author Affiliations

1: Laboratory of Cellular Physiology, Food and Drug Administration, Bethesda, MD 20892.

Articles citing this

Monoclonal antibodies to surface antigens of a pathogenic Mycoplasma hominis strain. Infect Immun (1991) 1.55

Localization of the promoter for the ptl genes of Bordetella pertussis, which encode proteins essential for secretion of pertussis toxin. Infect Immun (1995) 1.35

Detection and subcellular localization of three Ptl proteins involved in the secretion of pertussis toxin from Bordetella pertussis. J Bacteriol (1994) 1.28

DsbA and DsbC are required for secretion of pertussis toxin by Bordetella pertussis. Infect Immun (2002) 1.14

Monoclonal antibodies and toxins--a perspective on function and isotype. Toxins (Basel) (2012) 1.09

Engineering of genetically detoxified pertussis toxin analogs for development of a recombinant whooping cough vaccine. Infect Immun (1990) 1.08

Comparison of pertussis toxin (PT)-neutralizing activities and mouse-protective activities of anti-PT mouse monoclonal antibodies. Infect Immun (1991) 1.08

Mechanism of pertussis toxin B oligomer-mediated protection against Bordetella pertussis respiratory infection. Infect Immun (1990) 1.08

Expression and immunogenicity of pertussis toxin S1 subunit-tetanus toxin fragment C fusions in Salmonella typhi vaccine strain CVD 908. Infect Immun (1996) 1.07

Importance of holotoxin assembly in Ptl-mediated secretion of pertussis toxin from Bordetella pertussis. Infect Immun (2000) 1.05

Use of pertussis toxin encoded by ptx genes from Bordetella bronchiseptica to model the effects of antigenic drift of pertussis toxin on antibody neutralization. Infect Immun (2000) 1.00

Analysis of proteins encoded by the ptx and ptl genes of Bordetella bronchiseptica and Bordetella parapertussis. Infect Immun (1996) 0.99

Temporal expression of pertussis toxin and Ptl secretion proteins by Bordetella pertussis. J Bacteriol (2004) 0.94

Progress towards recombinant anti-infective antibodies. Recent Pat Antiinfect Drug Discov (2009) 0.88

Characterization of a key neutralizing epitope on pertussis toxin recognized by monoclonal antibody 1B7. Biochemistry (2009) 0.87

Membrane localization of the S1 subunit of pertussis toxin in Bordetella pertussis and implications for pertussis toxin secretion. Infect Immun (2002) 0.87

Characterization of murine monoclonal antibodies that recognize defined epitopes of pertussis toxin and neutralize its toxic effect on Chinese hamster ovary cells. Infect Immun (1991) 0.87

Essential role of the consensus nucleotide-binding site of PtlH in secretion of pertussis toxin from Bordetella pertussis. J Bacteriol (1997) 0.86

Molecular characterization of two Bordetella bronchiseptica strains isolated from children with coughs. J Clin Microbiol (1997) 0.86

Bordetella pertussis risA, but not risS, is required for maximal expression of Bvg-repressed genes. Infect Immun (2005) 0.83

Analysis of relative levels of production of pertussis toxin subunits and Ptl proteins in Bordetella pertussis. Infect Immun (2004) 0.80

Detection of antibodies inhibiting the ADP-ribosyltransferase activity of pertussis toxin in human serum. J Clin Microbiol (1992) 0.79

Monoclonal Antibody Combinations that Present Synergistic Neutralizing Activity: A Platform for Next-Generation Anti-Toxin Drugs. Toxins (Basel) (2015) 0.79

Analysis of subassemblies of pertussis toxin subunits in vivo and their interaction with the ptl transport apparatus. Infect Immun (2004) 0.77

Reduced glutathione is required for pertussis toxin secretion by Bordetella pertussis. Infect Immun (2003) 0.76

Human antibody response to the B oligomer of pertussis toxin. Clin Diagn Lab Immunol (1994) 0.75

Articles by these authors

Nature and rates of adverse reactions associated with DTP and DT immunizations in infants and children. Pediatrics (1981) 7.58

Establishment and characterization of BALB/c lymphoma lines with B cell properties. J Immunol (1979) 6.70

Induction of a novel morphological response in Chinese hamster ovary cells by pertussis toxin. Infect Immun (1983) 5.03

Extracytoplasmic adenylate cyclase of Bordetella pertussis. Proc Natl Acad Sci U S A (1976) 3.57

Apo2L/TRAIL-dependent recruitment of endogenous FADD and caspase-8 to death receptors 4 and 5. Immunity (2000) 3.45

Pertussis toxin. Affinity purification of a new ADP-ribosyltransferase. J Biol Chem (1983) 3.31

Ia antigen-bearing B cell tumor lines can present protein antigen and alloantigen in a major histocompatibility complex-restricted fashion to antigen-reactive T cells. J Exp Med (1982) 3.01

Bordetella pertussis filamentous hemagglutinin: evaluation as a protective antigen and colonization factor in a mouse respiratory infection model. Infect Immun (1990) 2.89

Interleukin-6 and soluble interleukin-6 receptors in the synovial fluids from rheumatoid arthritis patients are responsible for osteoclast-like cell formation. J Bone Miner Res (1996) 2.86

Separation and purification of the hemagglutinins from Bordetella pertussis. Infect Immun (1983) 2.85

Role of antibody to leukocytosis-promoting factor hemagglutinin and to filamentous hemagglutinin in immunity to pertussis. Infect Immun (1981) 2.77

Identification of a 69-kilodalton nonfimbrial protein as an agglutinogen of Bordetella pertussis. Infect Immun (1988) 2.55

ADP-ribosylation of transducin by pertussis toxin blocks the light-stimulated hydrolysis of GTP and cGMP in retinal photoreceptors. J Biol Chem (1984) 2.39

Identification of CRAMP, a cathelin-related antimicrobial peptide expressed in the embryonic and adult mouse. J Biol Chem (1997) 2.38

Aerosol infection of mice with Bordetella pertussis. Infect Immun (1980) 2.31

Phase-shift markers in Bordetella: alterations in envelope proteins. J Infect Dis (1981) 2.23

Filamentous hemagglutinin has a major role in mediating adherence of Bordetella pertussis to human WiDr cells. Infect Immun (1986) 2.18

Protective activities of the filamentous hemagglutinin and the lymphocytosis-promoting factor of Bordetella pertussis in mice. J Infect Dis (1984) 1.96

Sensitivity and specificity of clinical case definitions for pertussis. Am J Public Health (1988) 1.93

Comparison of type 2 and type 6 fimbriae of Bordetella pertussis by using agglutinating monoclonal antibodies. Infect Immun (1988) 1.92

Lectin-like binding of pertussis toxin to a 165-kilodalton Chinese hamster ovary cell glycoprotein. J Biol Chem (1988) 1.88

Activated human T cells directly induce osteoclastogenesis from human monocytes: possible role of T cells in bone destruction in rheumatoid arthritis patients. Arthritis Rheum (2001) 1.85

Intracellular localization of the dermonecrotic toxin of Bordetella pertussis. Infect Immun (1979) 1.83

Serological response to filamentous hemagglutinin and lymphocytosis-promoting toxin of Bordetella pertussis. Infect Immun (1983) 1.77

Energetics of glycylglycine transport in Escherichia coli. J Bacteriol (1974) 1.76

Agglutinating monoclonal antibodies that specifically recognize lipooligosaccharide A of Bordetella pertussis. Infect Immun (1988) 1.71

Immunologic response to early and routine DTP immunization in infants. Pediatrics (1984) 1.71

Binding of pertussis toxin to eucaryotic cells and glycoproteins. Infect Immun (1989) 1.71

More characters or more taxa for a robust phylogeny--case study from the coffee family (Rubiaceae). Syst Biol (1999) 1.68

Pertussis toxin substrate, the putative Ni component of adenylyl cyclases, is an alpha beta heterodimer regulated by guanine nucleotide and magnesium. Proc Natl Acad Sci U S A (1983) 1.67

Characterization of the protective capacity and immunogenicity of the 69-kD outer membrane protein of Bordetella pertussis. J Exp Med (1990) 1.67

Infants and children with convulsions and hypotonic-hyporesponsive episodes following diphtheria-tetanus-pertussis immunization: follow-up evaluation. Pediatrics (1988) 1.66

Properties of biomolecules measured from atomic force microscope images: a review. J Struct Biol (1997) 1.65

Regulation of the expression of IL-8 receptor A/B by IL-8: possible functions of each receptor. J Immunol (1995) 1.64

Ns and Ni, the stimulatory and inhibitory regulatory components of adenylyl cyclases. Purification of the human erythrocyte proteins without the use of activating regulatory ligands. J Biol Chem (1984) 1.62

Monoclonal antibodies detect different distribution patterns of IL-8 receptor A and IL-8 receptor B on human peripheral blood leukocytes. J Immunol (1994) 1.60

Stimulation and inhibition of adenylyl cyclases mediated by distinct regulatory proteins. Nature (1983) 1.59

Nonfermentative bacilli associated with man. I. Nomenclature. Am J Clin Pathol (1970) 1.57

ADP-ribosyltransferase activity of pertussis toxin and immunomodulation by Bordetella pertussis. Science (1988) 1.57

Role of the A subunit of pertussis toxin in alteration of Chinese hamster ovary cell morphology. Infect Immun (1987) 1.52

Mars' south polar Ar enhancement: a tracer for south polar seasonal meridional mixing. Science (2004) 1.52

Production of the RANTES chemokine in delayed-type hypersensitivity reactions: involvement of macrophages and endothelial cells. J Exp Med (1994) 1.49

Identification of Bordetella pertussis infection by shared-primer PCR. J Clin Microbiol (1994) 1.49

Evaluation of mixtures of purified Haemophilus influenzae outer membrane proteins in protection against challenge with nontypeable H. influenzae in the chinchilla otitis media model. Infect Immun (1993) 1.47

Bacterial virus contamination of fetal bovine sera. In Vitro (1973) 1.47

Purification and characterization of fimbriae isolated from Bordetella pertussis. Infect Immun (1985) 1.47

Isotype-dependent inhibition of tumor growth in vivo by monoclonal antibodies to death receptor 4. J Immunol (2001) 1.46

Pantothenate kinase-associated neurodegeneration in Korea: recurrent R440P mutation in PANK2 and outcome of deep brain stimulation. Eur J Neurol (2011) 1.46

Establishment of B cell hybridomas with B cell surface antigens. J Immunol (1982) 1.44

Characteristics of BALB/C T cell lymphomas grown as continuous in vitro lines. J Immunol (1978) 1.42

Contribution of Na(+)-glucose cotransport to the short-circuit current in the pigmented rabbit conjunctiva. Curr Eye Res (1996) 1.41

Alteration by cereolysin of the structure of cholesterol-containing membranes. Biochim Biophys Acta (1978) 1.40

Regulation of neutrophil interleukin 8 gene expression and protein secretion by LPS, TNF-alpha, and IL-1 beta. J Cell Physiol (1993) 1.39

Neutralization of IL-8 inhibits neutrophil influx in a rabbit model of endotoxin-induced pleurisy. J Immunol (1994) 1.39

A comparison of laboratory and clinical methods for diagnosing pertussis in an outbreak in a facility for the developmentally disabled. J Infect Dis (1988) 1.37

Abnormal glutathione transport in cystic fibrosis airway epithelia. Am J Physiol (1999) 1.36

Structural characterization of pertussis toxin A subunit. J Biol Chem (1987) 1.36

Immune response to the B oligomer of pertussis toxin. Infect Immun (1987) 1.36

Vascular endothelial growth factor promotes tumor dissemination by a mechanism distinct from its effect on primary tumor growth. Cancer Res (1996) 1.35

Tight monolayers of rat alveolar epithelial cells: bioelectric properties and active sodium transport. Am J Physiol (1989) 1.32

Epitopes on the S1 subunit of pertussis toxin recognized by monoclonal antibodies. Infect Immun (1989) 1.32

Protease Do is essential for survival of Escherichia coli at high temperatures: its identity with the htrA gene product. Biochem Biophys Res Commun (1991) 1.27

Leptospirosis in Chonbuk Province of Korea in 1987: a study of 93 patients. Am J Trop Med Hyg (1989) 1.27

Pertussis encephalopathy with a normal brain biopsy and elevated lymphocytosis-promoting factor antibodies. Pediatr Infect Dis (1984) 1.25

Pertussis toxin inhibition of chemotaxis and the ADP-ribosylation of a membrane protein in a human-mouse hybrid cell line. Proc Natl Acad Sci U S A (1985) 1.24

Mapping epitopes on the insulin molecule using monoclonal antibodies. Eur J Immunol (1983) 1.23

Macrophage cell lines produce a cytotoxin. J Immunol (1979) 1.22

The incidence and clinical characteristics of symptomatic propylthiouracil-induced hepatic injury in patients with hyperthyroidism: a single-center retrospective study. Am J Gastroenterol (2001) 1.21

Involvement of APO2 ligand/TRAIL in activation-induced death of Jurkat and human peripheral blood T cells. Eur J Immunol (1998) 1.19

Pertussis toxin analog with reduced enzymatic and biological activities is a protective immunogen. Infect Immun (1990) 1.19

Purification of cereolysin and the electrophoretic separation of the active (reduced) and inactive (oxidized) forms of the purified toxin. Infect Immun (1976) 1.17

Adenine nucleotides promote dissociation of pertussis toxin subunits. J Biol Chem (1986) 1.17

Immunological characterization of recombinant antigens isolated from a Mycobacterium avium lambda gt11 expression library by using monoclonal antibody probes. Infect Immun (1991) 1.17

Vitreoscilla hemoglobin. Intracellular localization and binding to membranes. J Biol Chem (2001) 1.17

Release of Ia antigens by a cultured B cell line. J Immunol (1980) 1.16

Structure, function, and molecular modeling approaches to the study of the intestinal dipeptide transporter PepT1. J Pharm Sci (1998) 1.15

Depressed interleukin-12 (IL-12), but not IL-18, production in response to a 30- or 32-kilodalton mycobacterial antigen in patients with active pulmonary tuberculosis. Infect Immun (2000) 1.13

Cloning and sequencing of the structural gene for the porin protein of Bordetella pertussis. Mol Microbiol (1991) 1.13

Monolayers of human alveolar epithelial cells in primary culture for pulmonary absorption and transport studies. Pharm Res (1999) 1.13

The phylogeny of the Asteridae sensu lato based on chloroplast ndhF gene sequences. Mol Phylogenet Evol (2000) 1.12

The gene fimU affects expression of Salmonella typhimurium type 1 fimbriae and is related to the Escherichia coli tRNA gene argU. Mol Gen Genet (1994) 1.12

In vitro inhibition of murine macrophage migration by Bordetella pertussis lymphocytosis-promoting factor. Infect Immun (1984) 1.12

The changes of histopathology and serum anti-sparganum IgG in experimental sparganosis of mice. Kisaengchunghak Chapchi (1989) 1.12